/Companies

Recolony

1 known investors

Find your way into Recolony

Sign up to see every warm intro you have to Recolony

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Recolony team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Adularia (Recolony) develops cancer immunotherapies based on microbiome research, using a microbial metabolite mechanism that activates tumor-residing macrophages to trigger an anti-tumor immune response. The company designs an optimized, tumor-targeted immunotherapy molecule using multi-omics and AI-driven molecule design.</parameter> <parameter name="founders">[{"full_name": "Ana Montalban-Arques", "title": "CEO & Co-Founder"}, {"full_name": "Philipp Busenhart", "title": "COO & Co-Founder"}, {"full_name": "Egl\u0117 Katkevi\u010di\u016bt\u0117", "title": "CSO & Co-Founder"}, {"full_name": "David Seeberger", "title": "CFO"}]

Investors · 1

Frequently asked questions

What does Recolony do?
Adularia (Recolony) develops cancer immunotherapies based on microbiome research, using a microbial metabolite mechanism that activates tumor-residing macrophages to trigger an anti-tumor immune response. The company designs an optimized, tumor-targeted immunotherapy molecule using multi-omics and AI-driven molecule design.</parameter> <parameter name="founders">[{"full_name": "Ana Montalban-Arques", "title": "CEO & Co-Founder"}, {"full_name": "Philipp Busenhart", "title": "COO & Co-Founder"}, {"full_name": "Egl\u0117 Katkevi\u010di\u016bt\u0117", "title": "CSO & Co-Founder"}, {"full_name": "David Seeberger", "title": "CFO"}]
Who are Recolony's investors?
Recolony's investors include Kickfund.